---
title: "Amotiv discloses lapse of performance rights held by director"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280081485.md"
description: "Amotiv discloses lapse of performance rights held by director"
datetime: "2026-03-23T01:37:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280081485.md)
  - [en](https://longbridge.com/en/news/280081485.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280081485.md)
---

# Amotiv discloses lapse of performance rights held by director

Amotiv discloses lapse of performance rights held by director

### Related Stocks

- [NOTV.US](https://longbridge.com/en/quote/NOTV.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IDNA.US](https://longbridge.com/en/quote/IDNA.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)

## Related News & Research

- [Roivant posts unexpected Q4 profit due to Moderna lawsuit settlement gain](https://longbridge.com/en/news/287053604.md)
- [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md)
- [BUZZ-Street View: Regeneron's melanoma trial setback raises bigger-picture questions](https://longbridge.com/en/news/286769076.md)
- [Enanta Pharma's RSV Bet And Immunology Ambitions](https://longbridge.com/en/news/286895623.md)
- [Immix Biopharma Announces 95% Complete Response Rate In Interim Update From Relapsed/Refractory AL Amyloidosis Clinical Trial NEXICART-2](https://longbridge.com/en/news/287200923.md)